Lunai Bioworks Inc. (LNAI)
Lunai Bioworks Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $1.93, down 0.52% on the session, giving a market capitalisation of $8.8M. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -612568.1%. Its beta of 0.34 implies it has historically moved less than the broad market.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Lunai Bioworks Inc. is most often compared with the following Healthcare names: